COMMUNIQUÉS West-GlobeNewswire

Ivy Brain Tumor Center and BridgeBio Subsidiary QED Therapeutics Announce Collaboration to Advance Cancer Research and Treatment Options
24/09/2019
Preclinical study designed to test investigational agent infigratinib for the treatment of glioblastoma PHOENIX, Sept. 24, 2019 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, today [...]
Constellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise
24/09/2019
Potential best-in-class EZH2 inhibitor focused on targeted patient segments was identified using Constellation’s epigenetics platform CAMBRIDGE, Mass., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , [...]
Aleafia Health Provides Guidance for Profitable Third Quarter 2019
24/09/2019
Company maintains strong balance sheet with $51 million in cash on hand Construction of Paris Phase II Processing facility expected to be completed in October 2019 Active, registered patients increased to over 10,000, a [...]
MediPharm Labs Enters European Medical Cannabis Market with German Pharmaceutical and Medical Cannabis Distributor ADREXpharma®
24/09/2019
First extraction-only company with supply agreement for export to Germany Second international distribution milestone further expands the Company’s global supply chain Demonstrates increasing international export [...]
Rexahn to Explore Strategic Alternatives
24/09/2019
ROCKVILLE, Md., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NasdaqCM: REXN) today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder [...]
European Commission Grants Orphan Drug Designation for Nirogacestat for the Treatment of Soft Tissue Sarcoma
24/09/2019
STAMFORD, Conn., Sept. 24, 2019 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare [...]
Fennec Appoints Jodi A. Cook, PhD to Its Board of Directors
24/09/2019
RESEARCH TRIANGLE PARK, N.C., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK TM (a unique formulation of [...]
BioAdaptives, Inc. Announces TizHemp, a New Hemp-Product Division, & Appointment of New CFO
24/09/2019
Las Vegas, Nevada, Sept. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioAdaptives, Inc. (OTC BB: BDPT) announced the Company’s formation of TizHemp, a new operating division to concentrate efforts on wellness- [...]
RadNet, Inc. to Present at the Sidoti & Company Fall 2019 Conference on Wednesday, September 25th
24/09/2019
LOS ANGELES, Sept. 24, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
CampDoc Launches Three-Year Research Partnership with the American Camp Association and the Association of Camp Nursing
24/09/2019
ANN ARBOR, Mich., Sept. 24, 2019 (GLOBE NEWSWIRE) -- CampDoc, the leading electronic health record system for camps , is pleased to announce a three-year research partnership with American Camp Association (ACA) and the [...]
Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia
24/09/2019
Company announcement – No. 35 / 2019 Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia Median time to recovery from low blood glucose in [...]
Next Green Wave Achieves Operational Milestones For Intrexon’s Botticelli™ Cannabis Plantlet Production
24/09/2019
NGW Nursery Capacity Established and Second Harvest Completed VANCOUVER, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", “NGW” or the " [...]
Transactions in relation to share buyback program
24/09/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
AgraFlora Organics Provides Operational Update and Sales License Guidance at AAA Heidelberg Craft Cannabis Facility
24/09/2019
VANCOUVER, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Preliminary results from Phase IIb Liproca® Depot dose-finding study show a strong maximum PSA decrease and sustained PSA reduction effect
24/09/2019
Study confirms Liproca® Depot’s potential as drug treatment for men with prostate cancer who currently are under ‘Active Surveillance’ and receiving no treatment UPPSALA, SWEDEN. LIDDS AB (publ) – LIDDS has today [...]
Publication of Prospectus and indicative price range related to the contemplated indirect public offering of Nordic Transport Group through NeuroSearch
24/09/2019
Company announcement no 26 - 19 24 September 2019 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER [...]
Significant next step to professionalize medical cannabis market: Cansativa and DaVinci announce partnership for development & production of medical cannabis vaporizers
24/09/2019
FRANKFURT AM MAIN, Germany, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Cansativa GmbH expands its portfolio with its Cansativa Medical Devices business. Medical devices entrepreneur Dr. Markus Haller becomes managing director. [...]
Addex Therapeutics Submits Registration Statement with the U.S. SEC to Facilitate Nasdaq Listing of ADSs Representing Shares
24/09/2019
Geneva, Switzerland, 24 September 2019 -- Addex Therapeutics Ltd (SIX: ADXN) (the Company), a leading company pioneering allosteric modulation-based drug discovery and development, today announced it has confidentially [...]
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
23/09/2019
Anchiano will make an upfront payment in exchange for the option to in-license at any time through obtaining an Investigational New Drug (IND) designation Company also provides update on accrual to its ongoing pivotal [...]

Pages